Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: An 11-year follow-up

Human Reproduction

Volumn 25, Issue 8, 2010, Pages 1966-1972

  Palomba, Stefano ^a   Falbo, Angela ^a   Del Negro, Serena ^a   Rocca, Morena ^a   Russo, Tiziana ^b   Cariati, Francesco ^a   Annunziata, Gianluca ^a   Tolino, Achille ^c   Tagliaferri, Pierosandro ^b   Zullo, Fulvio ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Cancer Center of Excellence Tommaso Campanella of Germaneto   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

BOTs; fertility sparing strategy; pregnancy; recurrence; ultra conservative surgery

Indexed keywords

GONADOTROPIN DERIVATIVE;

ARTICLE; BORDERLINE OVARIAN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; HEALTH PROGRAM; HUMAN; OVARIECTOMY; OVARY TUMOR; RANDOMIZED CONTROLLED TRIAL; SURGICAL APPROACH; TUMOR RECURRENCE;

EID: 77954992638     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq159     Document Type: Article

References (25)

1. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005;123:S13-S57.
2. Borgfeldt C, Iosif C, Masback A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007;134:110-114.
3. Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lécuru F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol 2005;98:390-395.
4. Farthing A. Conserving fertility in the management of gynaecological cancers. BJOG 2006;113:129-134.
5. Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 2007;105:542-544.
6. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987;156:263-264.
7. Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, Mäkinen J, Grénman S. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstet Gynecol Scand 2007;86:610-614.
8. Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol 2008;15:3561-3566.
9. Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P. Results after conservative treatment of serous borderline tumors of the ovary with stromal microinvasion but without micropapillary pattern. BJOG 2009; 116:860-862.
10. Liou WS, Yap OW, Chan JK, Westphal LM. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril 2005; 84:1561-1573.
11. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005;11:69-89.
12. Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol 2006;103:1109-1121.
13. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer 2006; 42:149-158.
14. Morice P, Camatte S, Wicart-Poque F, Atallah D, Rouzier R, Pautier P, Pomel C, Lhommé C, Duvillard P, Castaigne D. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003;9:185-192.
15. Palomba S, Falbo A, Orio F Jr, Manguso F, Russo T, Tolino A, Annamaria C, Dale B, Zullo F. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. Hum Reprod 2005;20:2879-2886.
16. Palomba S, Russo T, Falbo A, Orio F Jr, Manguso F, Nelaj E, Tolino A, Colao A, Dale B, Zullo F. Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study. Hum Reprod 2006; 21:1055-1061.
17. Palomba S, Zupi E, Russo T, Falbo A, Del Negro S, Manguso F, Marconi D, Tolino A, Zullo F. Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod 2007;22:578-585.
18. Palomba S, Russo T, Orio F Jr, Falbo A, Tolino A, Zullo F. Perifollicular vascularity assessment for selecting the best oocytes for in vitro fertilization programs in older patients. Fertil Steril 2008;90:1305-1309.
19. Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 2006;101:255-260.
20. Salomon LJ, Lhommé C, Pautier P, Duvillard P, Morice P. Safety of simple cystectomy in patients with unilateral mucinous borderline tumors. Fertil Steril 2006;85:1510.e1-1510.e4.
21. Taylor HC. Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet 1929;48:204-230.
22. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumours: a review. Gynecol Oncol 2006; 100:185-191.
23. Tinelli R, Malzoni M, Cosentino F, Perone C, Tinelli A, Malvasi A, Cicinelli E. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors. Fertil Steril 2009;92:736-741.
24. Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol 2010;21:55-60.
25. Wong HF, Low JJ, Chua Y, Busmanis I, Tay EH, Ho TH. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 2007;17:342-349.